Idera Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update

    NEXT STORY
    Conformis, Inc. Announces Clearance in Australia for iTotal® PS, the Only Personalized, Posterior-Stabilized Total Knee Replacement System
    PREV STORY
    Acer Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Apellis Announces 18-Month Data from Phase 1b Study of Pegcetacoplan in Patients with Geographic Atrophy (GA)

    author_avatar
    NASDAQ Market News

    Data From Prima BioMed AIPAC Clinical Trial to be Presented at 2017 ASCO Conference

    SYDNEY, Australia, May 17, 2017 (GLOBE NEWSWIRE) -- Prima BioMed Ltd (ASX:PRR) (NASDAQ:PBMD) (“Prima” ...

    author_avatar
    NASDAQ Market News

    Broad Network Providing Whole Blood Transfusions Transforms Trauma Care, Improves Survival Rates by 25 Percent

    South Texas man survives serious injuries thanks to Brothers in Arms blood donorSan Antonio, ...

    author_avatar
    NASDAQ Market News